EdgarLookup

ACADIA PHARMACEUTICALS INC — 8-K Filings

228 8-K filings on record

This page lists all 8-K filings submitted to the SEC by ACADIA PHARMACEUTICALS INC (ACAD), sorted by most recent first. Each row links to the full filing on EdgarLookup. ACADIA PHARMACEUTICALS INC has filed 228 8-K documents with the SEC since 2010. To view all SEC filings by ACADIA PHARMACEUTICALS INC, see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-Q 144 3 3/A 4 4/A 424B3 424B4 424B5 5 8-A12G 8-K 8-K/A ARS CORRESP CT ORDER D DEF 14A DEFA14A DEFR14A EFFECT POS AM PRE 14A REGDEX REGDEX/A RW S-1 S-1/A S-3 S-3/A S-3ASR S-3MEF S-8 S-8 POS SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
8-K 0001415889-12-000650 May 8, 2012
8-K 0001415889-12-000468 Mar 30, 2012
8-K 0001415889-12-000321 Mar 6, 2012
8-K 0001415889-12-000316 Mar 5, 2012 Feb 29, 2012
8-K 0001415889-11-001385 Dec 9, 2011
8-K 0001415889-11-001228 Nov 9, 2011
8-K 0001415889-11-000756 Aug 10, 2011
8-K 0001415889-11-000530 Jun 14, 2011
8-K FORM 8-K 0001193125-11-134194 May 10, 2011
8-K FORM 8-K 0001193125-11-093911 Apr 11, 2011 Apr 8, 2011
8-K FORM 8-K 0001193125-11-086780 Apr 1, 2011 Mar 28, 2011
8-K FORM 8-K 0001193125-11-062284 Mar 10, 2011
8-K FORM 8-K 0001193125-11-006698 Jan 12, 2011 Jan 9, 2011
8-K FORM 8-K 0001193125-10-254155 Nov 9, 2010
8-K FORM 8-K 0001193125-10-238754 Oct 28, 2010 Oct 27, 2010
8-K FORM 8-K 0001193125-10-216448 Sep 24, 2010 Sep 21, 2010
8-K FORM 8-K 0001193125-10-183327 Aug 9, 2010
8-K FORM 8-K 0001193125-10-179553 Aug 5, 2010 Aug 2, 2010
8-K FORM 8-K 0001193125-10-139760 Jun 15, 2010 Jun 11, 2010
8-K FORM 8-K 0001193125-10-114581 May 10, 2010
8-K FORM 8-K 0001193125-10-064507 Mar 23, 2010
8-K FORM 8-K 0001193125-10-051364 Mar 9, 2010
8-K FORM 8-K 0001193125-10-046869 Mar 3, 2010 Feb 25, 2010
8-K FORM 8-K 0001193125-10-015665 Jan 28, 2010 Jan 22, 2010
8-K FORM 8-K 0001193125-09-254965 Dec 17, 2009 Dec 11, 2009
8-K FORM 8-K 0001193125-09-229367 Nov 9, 2009
8-K FORM 8-K 0001193125-09-208586 Oct 15, 2009 Oct 14, 2009
8-K FORM 8-K 0001193125-09-204114 Oct 6, 2009 Oct 5, 2009
8-K FORM 8-K 0001193125-09-185421 Sep 1, 2009
8-K FORM 8-K 0001193125-09-165371 Aug 5, 2009
8-K FORM 8-K 0001193125-09-156923 Jul 28, 2009 Jul 23, 2009
8-K FORM 8-K 0001193125-09-107120 May 11, 2009
8-K 8-K FOR ENTERING INTO BIOVAIL AGREEMENT 0001181431-09-023421 May 7, 2009
8-K 8-K FOR ALLERGAN AMENDMENT 0001181431-09-021108 Apr 27, 2009
8-K FORM 8-K 0001193125-09-062726 Mar 25, 2009 Mar 24, 2009
8-K FORM 8-K 0001193125-09-048511 Mar 9, 2009
8-K FORM 8-K 0001193125-08-225833 Nov 5, 2008
8-K FORM 8-K 2Q08 EARNINGS 0001181431-08-046076 Aug 5, 2008
8-K 8-K ACP-104 PHASE IIB TRIAL 0001181431-08-038774 Jun 16, 2008
8-K FORM 8-K 0001193125-08-102301 May 5, 2008
8-K 8-K FOR LAURA A. BREGE ADDITION TO BOARD 0001181431-08-028638 May 5, 2008 May 1, 2008
8-K FORM 8-K 0001193125-08-050191 Mar 7, 2008 Mar 3, 2008
8-K FORM 8-K 0001193125-08-047833 Mar 5, 2008
8-K FORM 8-K 0001193125-07-235039 Nov 5, 2007
8-K FORM 8-K 0001193125-07-171970 Aug 6, 2007
8-K FORM 8-K 0001193125-07-106020 May 8, 2007
8-K FORM 8-K 0001193125-07-074759 Apr 5, 2007 Apr 4, 2007
8-K FORM 8-K 0001193125-07-070949 Apr 2, 2007 Mar 30, 2007
8-K FORM 8-K 0001193125-07-068972 Mar 30, 2007 Mar 29, 2007
8-K FORM 8-K 0001193125-07-057688 Mar 19, 2007